Clinical trials · New York
Obesity clinical trials in New York
We’re tracking 85 recruiting obesity studies with a site in New York — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT03402139Recruiting
Study early-life obesity risk after growth restriction
This study looks at how obesity risk may be influenced in children whose growth was lower than expected before birth. It enrolls mothers and babies together to learn whether early childhood obesity programming can help families.
The Bronx, New YorkAges 1 hour–2 years - NCT03880422Recruiting
Exercise and nutrition for weight and frailty after prostate cancer treatment
This study tests whether a structured exercise and nutrition program can improve obesity-related frailty and overall function in people with advanced prostate cancer who are taking hormone therapy (ADT). It may help with strength, mobility, and healthier body weight during/after ADT.
Buffalo, New YorkAges 18 years+ - NCT05935592Recruiting
Family phone tool to help kids at risk for weight gain
This study tests an interactive phone/tablet program for children and their parent or guardian, aiming to reduce the child’s risk of unhealthy weight gain. It may help by giving family-focused tips and support you can use at home.
The Bronx, New YorkAges 8–12 - NCT07639021RecruitingPhase 2
Testing Different Dose Schedules of a New Weight Loss Medicine
This study tests a new injectable medication (NNC0662-0419) designed to help people with obesity lose weight. Researchers are comparing different ways of increasing the dose to find the safest and most effective approach.
Westfield, New YorkAges 18 years+ - NCT06335810Recruiting
Reducing obesity with a buddy program
This study explores whether having a friend or family member join you in a weight-loss program helps reduce obesity. You and your buddy will use a food-tracking app and get support from the program.
New York, New YorkAges 18 years+ - NCT06412536Recruiting
Heart, weight, and hormone trial screening survey
This trial is a quick survey to find out if you may be eligible for future studies on heart health, weight, or hormone-related conditions. It helps researchers match you with the right treatment options.
Brooklyn, New YorkAges 18 years+ - NCT06557317Recruiting
Lifestyle program for Black teen girls at risk for type 2 diabetes
This study tests if an in-person lifestyle program can help prevent type 2 diabetes in Black adolescent girls who have obesity. The program involves both the teen and a caregiver who prepares most of the household meals.
Brooklyn, New YorkAges 12–18 - NCT06143956RecruitingPhase 2
Weight loss treatments for adults with obesity
This clinical trial tests new treatments for adults who are overweight or have obesity. The goal is to help people lose weight and improve their health.
Amherst, New YorkAges 18–75 - NCT06760546RecruitingPhase 3
Testing setmelanotide for weight gain after brain injury
This trial tests a daily injection called setmelanotide to see if it can help people who have gained weight due to a brain injury or condition affecting the hypothalamus. It may help reduce hunger and support weight loss.
New York, New YorkAges 4 years+ - NCT06857942RecruitingPhase 4
Tirzepatide added to ixekizumab for psoriasis and weight issues
This trial tests whether adding tirzepatide (a weight-loss and diabetes drug) to ixekizumab (a psoriasis treatment) helps people with moderate-to-severe psoriasis who are overweight or have obesity. It is for those already taking ixekizumab for about 3 months.
New York, New YorkAges 18 years+ - NCT06864026RecruitingPhase 4
Adding tirzepatide to ixekizumab for psoriatic arthritis with weight concerns
This study tests adding tirzepatide (a once-weekly injection for weight and diabetes) to your current treatment with ixekizumab for psoriatic arthritis. It may help with both joint symptoms and weight.
Rochester, New YorkAges 18 years+ - NCT07090005Recruiting
Endoscopic weight loss: comparing EndoZip and Apollo ESG
This study compares two different endoscopic procedures (EndoZip and Apollo ESG) to help obese patients lose weight. Both are done through the mouth without cutting the skin, and the goal is to see which works better and is safer.
New York, New YorkAges 21–65 - NCT07144800Recruiting
Family COMIDA: Helping Hispanic families eat healthier
This study aims to help Hispanic/Latino families who are overweight or have obesity eat healthier. It will test a program that includes text messages and video calls to support parents and their children aged 8–12.
New York, New YorkAges 18 years+ - NCT07229508Recruiting
Weight gain study for children from BIPOC or low-income families
This study looks at how children gain weight over time, especially in families of color or with low income. It helps understand why some kids struggle with weight and what can be done to help.
Buffalo, New YorkAges 8–11 - NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
Albany, New YorkAges 18–99 - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Long Island City, New YorkAges 18 years+ - NCT01998750Recruiting
Study of genes in severe early childhood obesity
This study looks for genetic (inherited) reasons for severe obesity that starts in very early childhood. It may help doctors better understand the cause of your child’s weight gain and guide future treatment.
New York, New YorkAges Up to 80 years - NCT02602769Recruiting
Testing blood traits in children with ROHHAD syndrome
This trial studies children with ROHHAD syndrome to better understand their body chemistry and other blood features. The results may help researchers learn what drives the condition and how it might be tracked over time.
Boston, New YorkAges 2–20 - NCT07564414RecruitingPhase 3
Weight Loss Study Comparing Two Doses of CagriSema
This study tests whether a new combination medication called CagriSema (in two different doses) helps people with obesity lose weight. You may qualify if you're 18 or older, have a BMI of 35 or higher, and either don't have type 2 diabetes or have it well-controlled.
West Seneca, New YorkAges 18 years+ - NCT07589608RecruitingPhase 2
Weight Loss Study With Two New Injectable Medications
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Amherst, New YorkAges 18–75 - NCT07641361Recruiting
Staying Hydrated to Feel Better on GLP-1 Medication
This study tests whether drinking more water helps reduce uncomfortable side effects (like nausea and vomiting) when you first start taking GLP-1 medications for weight loss or diabetes. You'll be asked to follow a hydration plan and report how you feel.
Buffalo, New YorkAges 18–60 - NCT07156578Enrolling by invitationPhase 2
Long-term bivamelagon for hypothalamic obesity
This long-term study tests a new drug, bivamelagon, for people with hypothalamic obesity. It's for those who already completed a similar study and tolerated the drug well.
New York, New YorkAges 12 years+ - NCT07667803RecruitingPhase 3
Study of elecoglipron for weight loss in obesity or overweight
This trial tests an investigational drug called elecoglipron to see if it helps people with obesity or overweight lose weight. It may be an option if you have a high body mass index or weight-related health issues like high blood pressure or prediabetes.
Albany, New YorkAges 18 years+ - NCT07225686RecruitingPhase 3
Maridebart Cafraglutide for sleep apnea in adults on CPAP
This study is testing whether a new medicine, called Maridebart Cafraglutide, can help people with obstructive sleep apnea who are already using a CPAP machine. The medicine may help with weight loss and potentially improve sleep apnea. Participants will either receive the medicine or a placebo (an inactive substance), and the study lasts for several months.
Laurelton, New YorkAges 18–99
Obesity trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting obesity studies listed above.
- Columbia University Irving Medical Center · 4 studies
- Dent Neurologic Institute · 2 studies
- Rochester Clinical Research, LLC · 2 studies
- State University of New York at Buffalo · 2 studies
- Basil Clinical
- Boston Children's Hospital
- Bronx Health Center - Children's Aid
- Brooklyn Clinical Research
What taking part in a obesity study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Obesity trials in other states
Common questions
- Are there obesity clinical trials in New York?
- Yes. We're currently tracking 85 recruiting obesity studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a obesity study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a obesity trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New obesity studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.